175 related articles for article (PubMed ID: 21386628)
1. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
2. Early detection and screening of pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Gonda TA; Saif MW
JOP; 2011 Mar; 12(2):83-5. PubMed ID: 21386626
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Chang BW; Saif MW
JOP; 2011 Mar; 12(2):101-5. PubMed ID: 21386630
[TBL] [Abstract][Full Text] [Related]
4. [Towards the identification of new markers of pancreatic cancer by gene expression analysis].
Rosty C
Bull Cancer; 2004; 91(7-8):593-8. PubMed ID: 15381449
[TBL] [Abstract][Full Text] [Related]
5. EUS-guided pancreatic diagnosis and beyond. Highlights from the "2011 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. January 20-22, 2011.
Vignesh S; Hoffe SE; Saif MW
JOP; 2011 Mar; 12(2):86-91. PubMed ID: 21386627
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: updates on translational research and future applications.
Sarris EG; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
[TBL] [Abstract][Full Text] [Related]
7. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
[TBL] [Abstract][Full Text] [Related]
8. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.
Denlinger CS; Cohen SJ
Curr Treat Options Oncol; 2007 Oct; 8(5):339-51. PubMed ID: 18193357
[TBL] [Abstract][Full Text] [Related]
9. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Kang SP; Saif MW
JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
[TBL] [Abstract][Full Text] [Related]
10. Translational research in pancreatic adenocarcinoma.
Kaur G; Saif MW
JOP; 2014 Mar; 15(2):121-3. PubMed ID: 24618433
[TBL] [Abstract][Full Text] [Related]
11. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Xu X; Strimpakos AS; Saif MW
JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
16. BRCA-associated pancreatic cancer: the evolving management.
Leung K; Saif MW
JOP; 2013 Mar; 14(2):149-51. PubMed ID: 23474559
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
Jazieh KA; Foote MB; Diaz LA
Semin Radiat Oncol; 2014 Apr; 24(2):67-76. PubMed ID: 24635863
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Pishvaian MJ; Brody JR
Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
[TBL] [Abstract][Full Text] [Related]
20. Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):120-2. PubMed ID: 21386635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
